CARL HURD: Open Payments
NPI 1346914256 · HAMPSTEAD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,312 in 100 payments from 13 companies in 2025. Trend: 2023 $979 · 2024 $1,529 · 2025 $6,312
Food & beverage: $3,041Consulting: $1,600Travel & lodging: $871Speaker / faculty: $800
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $4,155 |
| Vanda Pharmaceuticals Inc. | 14 | $473 |
| Otsuka America Pharmaceutical, Inc. | 12 | $438 |
| Axsome Therapeutics, Inc. | 8 | $344 |
| E.R. Squibb & Sons, L.L.C. | 3 | $259 |
| Braeburn Inc. | 6 | $237 |
| Teva Pharmaceuticals USA, Inc. | 20 | $222 |
| Alkermes, Inc. | 4 | $66 |
| Lundbeck LLC | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: CAPLYTA, REXULTI, Auvelity, COBENFY, FANAPT, BRIXADI, HETLIOZ, UZEDY.
Industry payments across NC — which companies pay providers there.
